UBS Group »

Aquestive Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6k 2.3k 2.02
2023-03-31 $4.3k 3.7k 1.14
2022-09-30 $15k 9.1k 1.60
2022-06-30 $0 415 0.00
2022-03-31 $2.1k 829 2.54
2021-12-31 $8.0k 2.0k 4.08
2021-09-30 $44k 10k 4.40
2021-06-30 $57k 14k 4.04
2021-03-31 $74k 14k 5.25
2020-12-31 $130k 24k 5.45
2020-09-30 $68k 14k 4.82
2020-06-30 $186k 38k 4.87
2020-03-31 $42k 19k 2.20
2019-12-31 $58k 10k 5.80
2019-09-30 $32k 10k 3.20
2019-06-30 $42k 10k 4.20
2019-03-31 $92k 13k 6.92
2018-09-30 $23k 1.3k 17.36